Clarithromycin-tailored cubosome: A sustained release oral nano platform for evaluating antibacterial, anti-biofilm, anti-inflammatory, anti-liver cancer, biocompatibility, ex-vivo and in-vivo studies

被引:1
作者
Abdullah, Hend Diaa [1 ]
Kamal, Islam [1 ]
Sabry, Shereen A. [2 ]
Abd Elghany, Mahmoud [2 ]
Ramadan, Abd El hakim [1 ]
机构
[1] Port Said Univ, Fac Pharm, Dept Pharmaceut, Port Said 42515, Egypt
[2] Zagazig Univ, Fac Pharm, Dept Pharmaceut, Zagazig 44519, Egypt
关键词
Cubosome; Clarithromycin; Antibacterial; Antibiofilm; Anti-inflammatory; Anti liver cancer; Sustained release; DRUG-DELIVERY-SYSTEM; LOADED CUBOSOMES; ANTIMICROBIAL ACTIVITY; VITRO; NANOPARTICLES; CYTOTOXICITY; PERMEATION; PHARMACOKINETICS; BIOAVAILABILITY; OPTIMIZATION;
D O I
10.1016/j.ijpharm.2024.124865
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The clinical implication of clarithromycin (CLT) is compromised owing to its poor solubility and, subsequently, bioavailability, unpalatable taste, rapid metabolism, short half-life, frequent dosing, and adverse effects. The present investigation provides an innovative sustained-release oral drug delivery strategy that tackles these challenges. Accordingly, CLT was loaded into a cubosome, a vesicular system with a bicontinuous cubic structure that promotes solubility and bioavailability, provides a sustained release system combating short half-life and adverse effects, masks unpleasant taste, and protects the drug from destruction in gastrointestinal tract (GIT). Nine various formulas were fabricated using the emulsification method. The resulting vesicles increased the encapsulation efficiency (EE %) from 57.64 f 0.04 % to 96.80 f 1.50 %, the particle size (PS) from 147.30 f 21.77 nm to 216.61 f 5.37 nm, and the polydispersity index (PDI) values ranged from 0.117 f 0.024 to 0.278 f 0.073. The zeta potential (ZP) changed from -20.65 f 2.01 mV to -33.98 f 2.60 mV. Further, the release profile exhibited a dual release pattern within 24 h., with the percentage of cumulative release (CR %) expanding from 30.06 f 0.42 % to 98.49 f 2.88 %, optimized formula was found to be CC9 with EE % = 96.80 f 1.50%, PS = 216.61 f 5.37 nm, ZP = -33.98 f 2.60 mV, PDI = 0.117 f 0.024, CR % = 98.49 f 2.88 % and IC50 of 0.74 f 0.19 mu g/mL against HepG-2 cells with scattered unilamellar cubic non-agglomerated vesicles. Additionally, it exhibited higher anti-MRSA biofilm, relative bioavailability (2.8 fold), and anti-inflammatory and antimicrobial capacity against Pseudomonas aeruginosa, Escherichia coli, Bacillus subtilis, and Staphylococcus aureus compared to free CLT. Our data demonstrate that cubosome is a powerful nanocarrier for oral delivery of CLT, boosting its biological impacts and pharmacokinetic profile.
引用
收藏
页数:17
相关论文
共 94 条
[1]  
Abbey T.C., 2019, CLIN MICROBIOL NEWSL, V41, P203, DOI [10.1016/j.clinmicnews.2019.11.002, DOI 10.1016/J.CLINMICNEWS.2019.11.002]
[2]   Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model [J].
Abdel-Hamid, Nagwa I. ;
El-Azab, Mona F. ;
Moustafa, Yasser M. .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (04) :379-395
[3]   The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation [J].
Abu-Khalaf, Nawaf ;
Zaid, Abdel Naser ;
Jaradat, Nidal ;
AlKilany, Alaaldin ;
Abu Rumaila, Basima ;
Al Ramahi, Rowa ;
Shweiki, Shrouq ;
Nidal, Safaa ;
Surakhi, Nibal .
SENSORS, 2018, 18 (02)
[4]   Cubosomes Dispersions as Enhanced Indomethacin Oral Delivery Systems: In vitro and Stability Evaluation [J].
Alfagih, Iman M. ;
AlQuadeib, Bushra ;
Aldosari, Basmah ;
Almurshedi, Alanood ;
Badran, Mohamed M. ;
Eltahir, Eram ;
Alnakhli, Khadijh A. .
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (25A) :24-35
[5]   Synthesis and biocompatibility of self-assembling multi-tailed resorcinarene-based supramolecular amphiphile [J].
Ali, Imdad ;
Saifullah, Salim ;
Imran, Muhammed ;
Nisar, Jan ;
Javed, Ibrahim ;
Shah, Muhammad Raza .
COLLOID AND POLYMER SCIENCE, 2020, 298 (4-5) :331-339
[6]   Enhancing the Solubility and Oral Bioavailability of Poorly Water-Soluble Drugs Using Monoolein Cubosomes [J].
Ali, Md. Ashraf ;
Kataoka, Noriko ;
Ranneh, Abdul-Hackam ;
Iwao, Yasunori ;
Noguchi, Shuji ;
Oka, Toshihiko ;
Itai, Shigeru .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2017, 65 (01) :42-48
[7]   Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate [J].
Allam, Ayat ;
Fetih, Gihan .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 :2421-2433
[8]   Cytotoxic Potential of Clarithromycin-Loaded Pumpkin Seed Oil-Based Nanoemulsion on Human Breast, Hepatic and Colorectal Cancer Cells [J].
Alotaibi, Hadil Faris ;
Khafagy, El-Sayed ;
Alfaifi, Mohammad Y. ;
Alamoudi, Jawaher Abdullah ;
Alshawwa, Samar Zuhair ;
Alqahtani, Rana Saeed ;
Alamrani, Sarah Salem ;
Abu Lila, Amr Selim .
SCIENCE OF ADVANCED MATERIALS, 2023, 15 (09) :1199-1207
[9]   Advances in Oral Drug Delivery [J].
Alqahtani, Mohammed S. ;
Kazi, Mohsin ;
Alsenaidy, Mohammad A. ;
Ahmad, Muhammad Z. .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[10]   Celecoxib-Loaded Cubosomal Nanoparticles as a Therapeutic Approach for Staphylococcus aureus In Vivo Infection [J].
Alshawwa, Samar Zuhair ;
El-Masry, Thanaa A. ;
Nasr, Mohamed ;
Kira, Ahmed Y. ;
Alotaibi, Hadil Faris ;
Sallam, Al-Sayed ;
Elekhnawy, Engy .
MICROORGANISMS, 2023, 11 (09)